- The stock price of BioNTech SE (NASDAQ: BNTX) increased by over 4% pre-market today. This is why it happened.
The stock price of BioNTech SE (NASDAQ: BNTX) increased by over 4% pre-market today. Investors are responding positively to a report that 3 doses of Pfizer and BioNTech’s vaccine provide a high level of protection against the omicron variant of COVID-19. And a booster shot of the vaccine increases antibody protection 25-fold compared to the initial two-dose series. The third shot shows virus-fight capabilities compared to the 95% protection provided by two doses against the original strain.
“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said Pfizer in a joint statement with BioNTech. “Ensuring as many people as possible are fully vaccinated with the first two-dose series and a booster remains the best course of action to prevent the spread of COVID-19.”
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.